Search Results

2016) where O-glycosylation contributes to the differential binding to CC or CX3C chemokine (Casarosa P sites in their N-termini that mediate ligand binding and signaling (Bannert N et al. 2001; Casarosa P glycosulfo peptide analogue GSnP-6 displays nanomolar affinity and promising potential for blocking PSGL-1/P-selectin

affinities from previous studies.[13] Besides traditional dopaminergic ligands, the affinities of the P- Therapeutics   2016 , 165 , 164–177. https://doi.org/10.1016/j.pharmthera.2016.06.007 . (2)         Sokoloff, P. P. U.; Lüdeke, S.; Koch, P.; Rinken, A.; Keller, M. T.; Schwille, P.; Jungmann, R.

Brian Krumm and Bryan Roth studied CryoEM structures of adhesion in GPCR CD97, filling gaps. challenge in the Dahl SS rat GPCRs in Neuroscience Neurokinin-2 receptor negatively modulates substance P

Liu ,  Marion Lanier ,   Brian K Shoichet ,  Esther Martinborough ,  Jonathan F Fay ,  Can Cao ,   Bryan receptors, data mapper, structure similarity search and models of physiological ligand complexes Luis P

.; Allongue, P.; Chazalviel, J.-N.; Gouget-Laemmel, A.

As GTP stabilizes and migrates towards the P loop, it causes the TCAT motif to shift, a key movement

bioinformatics tools offer the potential to explore larger portions of the β-arrestin interactome (Crépieux, P. with overlapping sites may experience mutually exclusive binding due to steric hindrance (Crépieux, P.

Thomas P.

and TM7 on the other hand, form possible dimerization interfaces (Ploier, B. et al. 2016; Dijkman, P.

Thomas P. Sakmar, Debbie L. Hay, Lukas Grätz, and more.

-P., Macdonald, C. B., Mehrotra, E., Patrick Rockefeller Grimes, Zahm, A. M., Trinidad, D.

They also showed higher protein levels of phospho-glycogen synthase kinase-3β (p-GSK3β), as well as total

Toxicol. 52, 179–197. https://doi.org/10. 1146/annurev.pharmtox.010909.105800 Tsao, P.

Bryan Roth There are 10 open tickets available. Get yours now!

Bryan Roth, Sudarshan Rajagopal, and Graeme Milligan. Save the date! Dr.

Bryan Roth's work on "Built-in functional selectivity in neurons is mediated by the neuronal protein,

Bryan Roth and Brian Krumm for their study on Molecular glues as potential GPCR therapeutics Drs.

Bryan L Roth study on Illuminating the understudied GPCR-ome Save the dates: February 8 - 29: Dr.

the adhesion GPCR ADGRG6/GPR126 is a key regulator of receptor signaling Jiankun Lyu, Brian Shoichet, Bryan

Therapy Research Structure Therapeutics Receives R&D Achievement of the Year Award for GPCR Research Bryan

Katharina Grotsch, Bryan L Roth, Valery V Fokin  et al. for their research on Virtual Screening of a

fantastic paper on Development of Putative Bivalent Dicovalent Ligands for the Adenosine A1 Receptor Bryan

Structural explanation of the receptor binding mechanism of a highly potent antagonist analog Isaikina, P.